MedAlerts Home
  Read the MedAlerts Blog Subscribe to the MedAlerts Blog 

Found 9444 cases where Vaccine is PNC13

Case Details (Reverse Sorted by Appearance Date)

This is page 83 out of 473

Result pages: prev   64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102   next


VAERS ID:516914 (history)  Vaccinated:2013-12-09
Age:1.0  Onset:2013-12-12, Days after vaccination: 3
Gender:Female  Submitted:2013-12-17, Days after onset: 5
Location:Illinois  Entered:2013-12-17
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data: EEG; CT of head; CBC; CMP; Urine drug screen
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
FLU4: INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT)SANOFI PASTEURU4793AA1UNRL
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETHG665393UNRL
VARCEL: VARICELLA (VARIVAX)MERCK & CO. INC.J0048160UNLL
Administered by: Private     Purchased by: Public
Symptoms: Computerised tomogram head, Convulsion, Depressed level of consciousness, Drug screen, Electroencephalogram, Full blood count, Lethargy, Metabolic function test
SMQs:, Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Convulsions (narrow), Drug abuse and dependence (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (narrow)
Write-up: Child became lethargic 12/12/13 in afternoon - had seizure - was unable to arouse baby - went to ER - transferred to another hospital by ambulance. Remained unable to arouse baby for total of 13 hours. Discharged 12/14/13.

VAERS ID:516839 (history)  Vaccinated:2013-04-18
Age:0.5  Onset:2013-04-21, Days after vaccination: 3
Gender:Female  Submitted:2013-12-16, Days after onset: 239
Location:Foreign  Entered:2013-12-17, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: 21-APR-2012, pH, 7.5 pH; Specific weight urine (21Apr2013): 1005; Pediatric examination, cardiological examination, ECG and EEG (unknown date): normal
CDC 'Split Type': 2013354788
Vaccination
Manufacturer
Lot
Dose
Route
Site
6VAX-F: DTAP+IPV+HEPB+HIB (FOREIGN)GLAXOSMITHKLINE BIOLOGICALSA21CB506A1IMUN
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETHF479201IMUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Cardiovascular evaluation, Electrocardiogram normal, Electroencephalogram normal, Hyporesponsive to stimuli, Hypotonia, Restlessness, Specific gravity urine increased, pH urine normal
SMQs:, Peripheral neuropathy (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Akathisia (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad)
Write-up: This is a spontaneous report received from the Regulatory Authority via a physician (contactable through Regulatory Authority only). Regulatory Authority report number 227732. A 6-month-old female patient received on 18Apr2013 at 09:34 second dose of PREVENAR 13 (lot number F47920, expiration date 31Jan2015) intramuscular and second dose of INFANRIX HEXA (lot number A21CB506A expiration date 30Jun2014) intramuscular. The patient medical history and concomitant medication were not reported. The patient experienced hypotonia, hyporesponsivity and restlessness on 21Apr2013. The seriousness criteria was hospitalization. On 21Apr2013 urine test was performed: all results were within normal range except for ph of 7.5 and specific weight of 1005. The patient underwent pediatric examination, cardiological examination, ECG and EEG (normal). The patient was treated with tachipirina and (for EEG sedation). On 22Apr2013 the patient completely recovered from the events.

VAERS ID:516633 (history)  Vaccinated:2013-12-13
Age:0.5  Onset:2013-12-13, Days after vaccination: 0
Gender:Male  Submitted:2013-12-16, Days after onset: 3
Location:Virginia  Entered:2013-12-16
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: No
Preexisting Conditions: Reflux
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTAPHEPBIP: DTAP + HEPB + IPV (PEDIARIX)GLAXOSMITHKLINE BIOLOGICALS4HP391IMLL
HIBV: HIB (PEDVAXHIB)MERCK & CO. INC.J0064171IMRL
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETHH044661IMRL
RV1: ROTAVIRUS (ROTARIX)GLAXOSMITHKLINE BIOLOGICALSA41FB380A1PO 
Administered by: Military     Purchased by: Military
Symptoms: Fatigue, Rash
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow)
Write-up: Facial Rash, Fatigue.

VAERS ID:516701 (history)  Vaccinated:2013-10-15
Age:0.3  Onset:0000-00-00
Gender:Male  Submitted:2013-12-16
Location:North Carolina  Entered:2013-12-16
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: No known illness
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTAPHEPBIP: DTAP + HEPB + IPV (PEDIARIX)GLAXOSMITHKLINE BIOLOGICALS55CY51IMLL
HIBV: HIB (PEDVAXHIB)MERCK & CO. INC.J0003601IMRL
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETHG497161IMRL
RV5: ROTAVIRUS (ROTATEQ)MERCK & CO. INC.J0023551IMUN
Administered by: Other     Purchased by: Unknown
Symptoms: Injection site discharge, Injection site erythema, Injection site rash, Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Extravasation events (injections, infusions and implants) (broad), Hypersensitivity (narrow)
Write-up: Prevnar 13 and HIB given in right leg at 4 month visit that left raised red bumps with clear drainage. Mom states had fever after vaccines but did not report to physician until next checkup at 6 month visit on 12/16/13. No pain at injection sites. Dr. will treat for possible infection.

VAERS ID:516712 (history)  Vaccinated:2013-10-29
Age:91.0  Onset:2013-10-29, Days after vaccination: 0
Gender:Male  Submitted:2013-12-03, Days after onset: 35
Location:California  Entered:2013-12-16, Days after submission: 13
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: Actinic Keratosis
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
FLU3: INFLUENZA (SEASONAL) (AFLURIA)CSL LIMITEDR542071UNLA
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETHG057871UNLA
Administered by: Other     Purchased by: Other
Symptoms: Rash
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow)
Write-up: Rash.

VAERS ID:516724 (history)  Vaccinated:2013-06-14
Age:0.4  Onset:2013-06-15, Days after vaccination: 1
Gender:Male  Submitted:2013-12-09, Days after onset: 177
Location:Florida  Entered:2013-12-16, Days after submission: 7
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: Severe GERd
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
HIBV: HIB (PEDVAXHIB)MERCK & CO. INC.J0003580UNLL
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETHG329870UNRL
Administered by: Private     Purchased by: Private
Symptoms: Condition aggravated, Diet refusal, Gastrooesophageal reflux disease, Insomnia, Pain, Pyrexia, Screaming, Vomiting
SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Gastrointestinal nonspecific dysfunction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hostility/aggression (broad)
Write-up: Son screamed in pain for 5 days. Day 1: Screamed 24 hrs straight without sleeping. Refused to eat for 2 days. Exacerbated severe GERD symptoms, vomiting, fever 101 degrees F.

VAERS ID:516774 (history)  Vaccinated:2013-12-03
Age:0.2  Onset:2013-12-11, Days after vaccination: 8
Gender:Female  Submitted:2013-12-16, Days after onset: 5
Location:Louisiana  Entered:2013-12-16
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: no
Preexisting Conditions: no
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTAPHEPBIP: DTAP + HEPB + IPV (PEDIARIX)GLAXOSMITHKLINE BIOLOGICALS55CY50IMRL
HIBV: HIB (ACTHIB)SANOFI PASTEURUH964AA0IMRL
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETH6392920IMLL
RV5: ROTAVIRUS (ROTATEQ)MERCK & CO. INC.H0162590PO 
Administered by: Private     Purchased by: Unknown
Symptoms: Intussusception
SMQs:, Gastrointestinal obstruction (narrow)
Write-up: Patient was admitted to hospital on 12/12/2013 as a transfer from an outside hospital with intussusception.

VAERS ID:516696 (history)  Vaccinated:2013-03-01
Age:  Onset:0000-00-00
Gender:Female  Submitted:2013-12-12
Location:Foreign  Entered:2013-12-16, Days after submission: 4
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': 2013352722
Vaccination
Manufacturer
Lot
Dose
Route
Site
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETH  SCUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Gastroenteritis
SMQs:, Noninfectious diarrhoea (broad)
Write-up: This is a spontaneous report from a non-contactable consumer received through the Agency. Regulatory authority report number 1092. An infant female patient of unknown ethnicity received PREVENAR 0.5 mL solution for injection in a pre-filled syringe subcutaneously on an unspecified date in Mar2013. There were 2 unspecified co-suspect medications. Neither relevant medical history nor concomitant medications were reported. On an unspecified date, the patient developed acute gastroenteritis assessed as medically significant by the regulatory authority. According to the PMDA, the cost of medical care and medical allowance were provided to the patient due to the event. The clinical outcome of the event, acute gastroenteritis was reported as unknown. This case was reported as a case of Adverse Drug Reaction Relief System which was to compensate for death, health damages requiring hospitalization (including a degree of hospitalization which the patient was treated at home involuntarily although its condition was considered to require hospitalization), disabilities caused by appropriately used prescribed and purchased drugs.

VAERS ID:516617 (history)  Vaccinated:2013-12-11
Age:1.7  Onset:2013-12-11, Days after vaccination: 0
Gender:Male  Submitted:2013-12-14, Days after onset: 3
Location:Illinois  Entered:2013-12-14
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: None
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETH 0IMLL
Administered by: Unknown     Purchased by: Other
Symptoms: Crying, Erythema, Gait disturbance, Mobility decreased, Pain, Pain in extremity, Pyrexia, Swelling
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Peripheral neuropathy (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Depression (excl suicide and self injury) (broad), Hypersensitivity (broad)
Write-up: Pain, inability/refusal to move leg which he kept bent at the hip and knee, uncontrollable crying, redness, and swelling. I gave 1 tsp Motrin at 9:00pm and then every 6 hours for 36 hrs. He cried continuously until 4:04am when he fell asleep. He woke at 7:40 am with a fever of 101.6 F. He cried off and on throughout 12/12/2013. He refused to walk for 30 hrs from onset of symptoms.

VAERS ID:516480 (history)  Vaccinated:2013-10-18
Age:1.0  Onset:2013-10-18, Days after vaccination: 0
Gender:Female  Submitted:2013-12-13, Days after onset: 56
Location:Georga  Entered:2013-12-13
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: Milk intolerance
Diagnostic Lab Data: Positive Salmonella stool culture
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEPA: HEP A (HAVRIX)GLAXOSMITHKLINE BIOLOGICALS494G50IMLL
MMRV: MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.J0072030IMLL
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETHH174273IMRL
Administered by: Unknown     Purchased by: Private
Symptoms: Culture stool positive, Diarrhoea, Pyrexia, Salmonella test positive
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Pseudomembranous colitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Noninfectious diarrhoea (narrow)
Write-up: High fever up to 105 within 24 hours of receiving 12 mos vaccines. Evaluated by ED. Tests and work up as cause for fever negative. On day 10 of fever, developed diarrhea. Fever defervesced but diarrhea continued. Stools cultures sent- positive for Salmonella.

VAERS ID:516587 (history)  Vaccinated:2013-12-12
Age:0.2  Onset:2013-12-12, Days after vaccination: 0
Gender:Female  Submitted:2013-12-13, Days after onset: 1
Location:California  Entered:2013-12-13
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: None
Diagnostic Lab Data: None
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTAPHEPBIP: DTAP + HEPB + IPV (PEDIARIX)GLAXOSMITHKLINE BIOLOGICALSAC21B399BA0IMLL
IPV: POLIO VIRUS, INACT. (POLIOVAX)SANOFI PASTEURJ13820IMRL
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETHG624340IMLL
RV5: ROTAVIRUS (ROTATEQ)MERCK & CO. INC.J0012520PO 
Administered by: Other     Purchased by: Public
Symptoms: Incorrect dose administered
SMQs:
Write-up: Single dose polio was given with Pediarix.

VAERS ID:516604 (history)  Vaccinated:2013-12-02
Age:1.6  Onset:0000-00-00
Gender:Male  Submitted:2013-12-13
Location:Michigan  Entered:2013-12-13
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: No
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTAP: DTAP (INFANRIX)GLAXOSMITHKLINE BIOLOGICALSAC14B157CA IMLL
MMR: MEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.J002502 SCLL
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETHG63300 IMRL
Administered by: Private     Purchased by: Public
Symptoms: Rash, Vaccination complication
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow)
Write-up: Rash on stomach no fever or other symptoms leading to rash as illness thus believing its a reaction to the MMR.

VAERS ID:516679 (history)  Vaccinated:2013-10-22
Age:0.2  Onset:2013-10-22, Days after vaccination: 0
Gender:Male  Submitted:2013-12-12, Days after onset: 51
Location:California  Entered:2013-12-13, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: None
Diagnostic Lab Data: None
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
HIBV: HIB (ACTHIB)SANOFI PASTEURUH845AA0IMLG
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETHG750640IMLG
RV5: ROTAVIRUS (ROTATEQ)MERCK & CO. INC.J0012540PO 
Administered by: Private     Purchased by: Other
Symptoms: Injection site erythema, Injection site swelling
SMQs:, Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow)
Write-up: 2" swelling and erythema at injection site. Self resolved over 72 hrs w/o treatment.

VAERS ID:516554 (history)  Vaccinated:2009-12-01
Age:1.0  Onset:2009-12-01, Days after vaccination: 0
Gender:Female  Submitted:2013-12-11, Days after onset: 1471
Location:Foreign  Entered:2013-12-13, Days after submission: 2
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: No patient''s medical history reported.
Diagnostic Lab Data: Allergy test, aluminium allergy (reaction type 4)
CDC 'Split Type': 2013SA128090
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTPIPV: DTP + IPV (NO BRAND NAME)UNKNOWN MANUFACTURER  IMUN
HIBV: HIB (ACTHIB)SANOFI PASTEUR  IMUN
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETH  IMUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Allergy test positive, Allergy to metals, Granuloma
SMQs:, Hypersensitivity (narrow)
Write-up: This case was received from an agency (E2013-10380). Case received from a health care professional via the Health Authorities in a foreign country and other company on 05-Dec-2013 under the references DK-DKMA-ADR 22337307 and DK-DKMA-EFO7648. Case is medically confirmed. The primary reporter was a physician. An 11-month-old female patient (weight, height not reported) with no medical history reported had received a dose of ACTHIB (batch number not reported) and a dose of DI-TE-KI-POL (batch number not reported) via intramuscular route into not reported site of administration on 01-Dec-2009. On the same day, the patient received a dose of PREVENAR 13 (Pfizer, batch number not reported) via intramuscular route into not reported site of administration which was not considered as suspect by the HA. On 01-Dec-2009, the patient developed aluminium granuloma. On an unspecified date, the patient developed allergy to aluminium. Patch test for aluminium was positive (allergy test, type 4 reaction). At the time of reporting, the patient had not recovered.

VAERS ID:516559 (history)  Vaccinated:2012-07-12
Age:0.2  Onset:2012-09-12, Days after vaccination: 62
Gender:Female  Submitted:2013-12-12, Days after onset: 456
Location:Foreign  Entered:2013-12-13, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Body temperature 40-41 degrees C (12Sep2012)
CDC 'Split Type': 2013351986
Vaccination
Manufacturer
Lot
Dose
Route
Site
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETHF639631UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Hyporesponsive to stimuli, Pyrexia, Somnolence
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Dementia (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad)
Write-up: This is a spontaneous report received from the foreign regulatory authority. Regulatory authority report number 227428. A contactable hospital physician reported that a 4-month-old female patient of an unspecified ethnicity received second dose of PREVENAR 13 (lot number F63963 and expiry date 01Jul2014), 12Jul2012 and second dose of INFANRIX HEXA (lot number A21CB286A expiry date 01Dec2014), via an unspecified route of administration on an unspecified date. The patient medical history and concomitant medications were not reported. On 12Sep2012, the patient experienced fever of 40-41 degrees C for two days and somnolence and poor response to stimuli. The events were medically significant. As therapeutic measure, upon previous call to the pediatrician, the child was put into a tub of cold water. Treatment also included Tachipirina syrup 5 ml for 2 times. The outcome was unknown.

VAERS ID:516562 (history)  Vaccinated:0000-00-00
Age:  Onset:0000-00-00
Gender:Female  Submitted:2013-12-12
Location:Foreign  Entered:2013-12-13, Days after submission: 1
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data:
CDC 'Split Type': 2013349654
Vaccination
Manufacturer
Lot
Dose
Route
Site
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETH  UNUN
Administered by: Unknown     Purchased by: Unknown
Symptoms: Cellulitis
SMQs:
Write-up: This is a spontaneous report from a contactable physician via Pfizer sales representative. A female patient (age unknown) was administered PREVENAR 13 adult use at the reporter''s hospital. After the administration, pus and inflammation occurred at the arm. At the first time, the patient visited a local clinic, and came to the reporter''s hospital again. The patient was hospitalized due to cellulitis. The reporter refused to provide additional information. Case closed (09Dec2013). Follow-up attempts completed. No further information expected.

VAERS ID:516327 (history)  Vaccinated:2013-12-06
Age:3.0  Onset:0000-00-00
Gender:Female  Submitted:0000-00-00
Location:Ohio  Entered:2013-12-12
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Autistic Spectrum Disorder
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
HEPA: HEP A (VAQTA)MERCK & CO. INC.J0057131IMRL
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETHH345113IMLL
Administered by: Private     Purchased by: Private
Symptoms: Vaccination site erythema, Vaccination site swelling
SMQs:
Write-up: Erythremia and swelling localized to L thigh area around 5 cm around vaccination site.

VAERS ID:516330 (history)  Vaccinated:2013-08-01
Age:  Onset:2013-08-01, Days after vaccination: 0
Gender:Unknown  Submitted:2013-12-12, Days after onset: 133
Location:Unknown  Entered:2013-12-12
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: Immunodeficiency
Diagnostic Lab Data:
CDC 'Split Type': WAES1312USA003536
Vaccination
Manufacturer
Lot
Dose
Route
Site
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETH  UNUN
Administered by: Other     Purchased by: Other
Symptoms: No adverse event, Wrong drug administered
SMQs:
Write-up: This spontaneous report as received from a registered nurse refers to a immunocompromised patient of unknown age (gender not reported). The nurse reported that the patient was administered a first dose of PNEUMOVAX23 (lot#, route and dose not reported) on an unspecified date in August 2006 and was revaccinated with PREVNAR 13 (manufacturer unknown) (lot#, route and dose not reported) on an unspecified date in August 2013. The patient's unspecified physician requested that the patient be vaccinated again with PNEUMOVAX23. A second dose of PNEUMOVAX23 has not been administered at this time. No adverse effects reported. Additional information has been requested.

VAERS ID:516374 (history)  Vaccinated:2013-12-06
Age:0.2  Onset:2013-12-06, Days after vaccination: 0
Gender:Female  Submitted:2013-12-12, Days after onset: 6
Location:Nebraska  Entered:2013-12-12
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NONE
Preexisting Conditions: NONE
Diagnostic Lab Data:
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTAPHEPBIP: DTAP + HEPB + IPV (PEDIARIX)GLAXOSMITHKLINE BIOLOGICALS 0IM 
HIBV: HIB (PEDVAXHIB)MERCK & CO. INC. 0IM 
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETH 0IM 
RV5: ROTAVIRUS (ROTATEQ)MERCK & CO. INC. 0PO 
Administered by: Unknown     Purchased by: Private
Symptoms: Body temperature increased, Decreased appetite, Irritability
SMQs:, Neuroleptic malignant syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad)
Write-up: VERY FUSSY, NOT EATING WELL, TEMP 101.5.

VAERS ID:516377 (history)  Vaccinated:2013-12-06
Age:0.5  Onset:2013-12-08, Days after vaccination: 2
Gender:Male  Submitted:2013-12-12, Days after onset: 4
Location:Michigan  Entered:2013-12-12
Life Threatening? No
Died? No
Permanent Disability? No
Recovered? Yes
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: None
Preexisting Conditions: Laryngomalacia
Diagnostic Lab Data: None
CDC 'Split Type':
Vaccination
Manufacturer
Lot
Dose
Route
Site
DTAPHEPBIP: DTAP + HEPB + IPV (PEDIARIX)GLAXOSMITHKLINE BIOLOGICALSJ9MS42IMRL
FLU3: INFLUENZA (SEASONAL) (FLUZONE)SANOFI PASTEURU4694EA0IMRL
PNC13: PNEUMO (PREVNAR13)PFIZER/WYETHG392912IMLL
RV5: ROTAVIRUS (ROTATEQ)MERCK & CO. INC.J0083852PO 
Administered by: Public     Purchased by: Public
Symptoms: Febrile convulsion
SMQs:, Convulsions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Generalised convulsive seizures following immunisation (narrow)
Write-up: Febrile seizure within 48 hours of receiving vaccines. No other neurological hx of seizures.

Result pages: prev   64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102   next

New Search

Link To This Search Result:
http://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=83&PERPAGE=20&ESORT=ENTR
Y-DATE&REVERSESORT=ON&VAX[]=PNC13


Copyright © 2014 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166